Document is current

Article History

Received: 25 October 2024

Accepted: 20 February 2025

First Online: 16 April 2025

Declarations

:

: Eliazar Sabater Cabrera and Magdalena Schwarz are employed by GSK. Eliazar Sabater Cabrera, Magdalena Schwarz and Claire Trennery hold financial equities in GSK. Adelphi Values (employer of Claire Trennery, Amy Jones and Natasha Griffiths) received grant/research support from GSK. Elizabeth Foley received advisory/consulting fees from GSK. Matthew Hamill received advisory/consulting fees from GSK and Chembio Diagnostics, as well as honoraria from GSK, Chembio Diagnostics, UpToDate and BMJ. Matthew Hamill also received kits for research projects from Chembio Diagnostics, Hologic, Roche and Cepheid.

: This study was conducted according to the principles outlined in the Declaration of Helsinki and in line with the Good Clinical Practice guidelines. Ethical approval for this study was provided by the Western Copernicus Group Institutional Review Board (IRB) in the US (IRB tracking number: 20221648). Participants were informed about the study's nature, purpose, their rights, risks and benefits both through written information and verbal communication. They were given the opportunity to ask questions, withdraw at any time and were assured of confidentiality and data protection according to HIPAA regulations before signing the informed consent form and participating in the study. Participants received honoraria of US$ 125 (via bank transfer/gift vouchers) upon completion of the interview. Such patient honoraria are permitted in the US and were reviewed and approved by the IRB.